The Autoimmune Association of South Africa (AASA) calls for the Council for Medical Schemes (CMS) to issue clear guidance on medical schemes’ obligations to cover costly specialised treatments for autoimmune diseases amidst growing patient disputes.
Group urges clarification on cover for autoimmune diseases
Original Article by Tamar Kahn | Business Day | 2 September 2024
The Autoimmune Association of South Africa (AASA) calls for the Council for Medical Schemes (CMS) to issue clear guidance on medical schemes’ obligations to cover costly specialised treatments for autoimmune diseases amidst growing patient disputes.